150 North Wacker Drive
Suite 1870
Chicago, IL 60606
847-381-5465 Phone
847-381-4606 Fax

User Information

Create New Account

Lost Password


Quick Links

LCDs and LCAs
by Contractor

PLA Codes

Laboratory Fee Schedule

2020 (July)

Physician Fee Schedule


OPPS Fee Schedule


ASC Fee Schedule


APC Codes


DRG Codes


ASP Drug Pricing Files

April 2021
January 2021

CMS Transmittals

Next Webinar 05/19/2021:
How to Structure Financial Arrangements with Customers

CodeMap® LCD-L36256


Printer Friendly Version

LCD for MolDX: Molecular Diagnostic Tests (MDT) (L36256)
See related Articles:
A54358-Billing and Coding: MolDX: Afirma™ Assay by Veracyte
A54366-Billing and Coding: MolDX: AlloMap
A54378-Billing and Coding: MolDX: Avise PG Assay
A54388-Billing and Coding: MolDX: bioTheranostics Cancer TYPE ID®
A54420-Billing and Coding: MolDX: FDA-Approved BRAF Tests
A54424-Billing and Coding: MolDX: FDA-Approved EGFR Tests
A54439-Billing and Coding: MolDX: HERmark® Assay by Monogram
A54447-Billing and Coding: MolDX: MammaPrint
A54482-Billing and Coding: MolDX: Oncotype DX® Breast Cancer Assay
A54486-Billing and Coding: MolDX: Oncotype DX® Colon Cancer
A54492-Billing and Coding: MolDX: Progensa® PCA3 Assay
A54496-Billing and Coding: MolDx: ResponseDX Tissue of Origin®
A54500-Billing and Coding: MolDX: FDA-Approved KRAS Tests
A54505-Billing and Coding: MolDX: Vectra™ DA
A54554-Response to Comments: MolDX: Molecular Diagnostic Tests (MDT)
A55295-Billing and Coding: MolDX: Myriad’s BRACAnalysis CDx®
A55712-Billing and Coding: MolDX: Abbott RealTime IDH1 and IDH2 testing for Acute Myeloid Leukemia (AML)
A55888-Billing and Coding: MolDX: ThermoFisher Oncomine Dx Target Test For Non-Small Cell Lung Cancer
A57527-Billing and Coding: MolDX: Molecular Diagnostic Tests (MDT)

Contractor Information

Contractor Name: Noridian Healthcare Solutions, LLC - Full list of policies of this Medicare Contractor

Contractor Number: 02401

Contractor Type: MAC A

LCD Information

LCD ID Number: L36256 Status: A-Approved

LCD Title: MolDX: Molecular Diagnostic Tests (MDT)

Geographic Jurisdiction: Washington Other Jurisdictions

Original Determination Effective Date: 10/01/2015

Original Determination Ending Date:

Revision Effective Date: 11/01/2019

Revision End Date:

CMS National Coverage Policy:

Title XVIII of the Social Security Act (SSA) §1862(a)(1)(A), states that no Medicare payment shall be made for items or services that "are not reasonable and necessary for the diagnosis or treatment of illness or injury or to improve the functioning of malformed body member."

Title XVIII of the Social Security Act (SSA) §1862(a)(1)(D), Investigational or Experimental.

45 CFR §162.1002 (a)(5)

Publication 100-08 PIM, Ch. 13, Sec 13.1.3, Program Integrity Manual, LCDs consist of only “reasonable and necessary” information.

Sorry, you need to login or register to view additional sections of this Medicare policy.

All information on this web site is compiled directly from information obtained from the Center for Medicare and Medicaid Services (CMS) and from its Contractors.

CodeMap® has made every reasonable effort to ensure the accuracy of the information contained on this web site. However, the ultimate responsibility for correct coding and claims submission lies with the provider of services. CodeMap® makes no representation, warranty, or guarantee that this compilation of Medicare information is error-free or that the use of this information will result in Medicare coverage and subsequent payment of claims. Final coverage and payment of claims are subject to many factors exclusively controlled by CMS and its contractors.

No part of this web page or data displayed may be redistibuted or used without the express written consent of Wheaton Partners, LLC.

05/10/2021 11:48:58

CodeMap® is a Registered Trademark of Wheaton Partners, LLC.